BBWI vs REYN
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BBWI's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability. The stock appears undervalued based on a low P/E of 6.87 and an intrinsic value estimate of $22.61, close to the current price of $22.20. However, declining revenue and earnings growth, along with negative Price/Book, raise sustainability concerns. While profitability margins and ROA are strong relative to peers, weak recent earnings surprises and bearish technical trends cap upside potential.
REYN exhibits a stable financial profile with a Piotroski F-Score of 6/9 and a healthy current ratio of 1.93, though it lacks a definitive Altman Z-Score. While the company is significantly more profitable and less levered than its sector peers, it suffers from stagnant revenue growth (1.40%) and slightly negative earnings growth (-2.30%). The stock is currently trading at a premium to both its Graham Number ($18.57) and Intrinsic Value ($10.01), suggesting limited valuation upside. The investment case rests primarily on its 4.12% dividend yield and consistent earnings beat track record, offset by a bearish technical trend.
Compare Another Pair
Related Comparisons
BBWI vs REYN: Head-to-Head Comparison
This page compares Bath & Body Works, Inc. (BBWI) and Reynolds Consumer Products Inc. (REYN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.